Operating CF
$10.76B
Capex
−$2.16B
Free Cash Flow
$8.60B
FCF Margin
+79.9%
Cash flow waterfall for Amgen (AMGN) — TTM through Q1 2026
Free cash flow: $8.60B
Cash flow breakdown for Amgen (AMGN) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Operating Cash Flow | $10.76B | $10.76B |
| Capital Expenditure | −$2.16B | $8.60B |
| Free Cash Flow | $8.60B | $8.60B |
| Other Investing | −$53.00M | $8.54B |
| Dividends Paid | −$5.20B | $3.34B |
| Other Financing & FX | −$113.00M | $3.23B |
| Net Cash Increase | $3.23B | $3.23B |
- Operating Cash Flow$10.76B
- Capital Expenditure−$2.16B
- Free Cash Flow$8.60B
- Other Investing−$53.00M
- Dividends Paid−$5.20B
- Other Financing & FX−$113.00M
- Net Cash Increase$3.23B
Want to see what drove the FCF change?Free Cash Flow Bridge
Frequently asked questions
Data & methodology
Amgen (AMGN) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement